Insight Molecular Diagnostics (IMDX) Depreciation & Amortization (CF) (2015 - 2026)
Insight Molecular Diagnostics (IMDX) posted Depreciation & Amortization (CF) of $631000.0 for Q1 2026, up 5.17% sequentially from $600000.0 in Q4 2025, and up 28.51% YoY from $491000.0 in Q1 2025.
Insight Molecular Diagnostics (IMDX) Depreciation & Amortization (CF) (2015 - 2026) Analysis & Trends
Insight Molecular Diagnostics (IMDX) has 12 years of Depreciation & Amortization (CF) data on file, last reported at $631000.0 in Q1 2026.
- Quarterly Depreciation & Amortization (CF) rose 28.51% year-over-year to $631000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.4 million (up 41.48% YoY) and the FY2025 annual result came in at $2.2 million, up 46.67% from the prior year.
- Depreciation & Amortization (CF) grew to $631000.0 in Q1 2026 per IMDX's latest filing, from $600000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $631000.0 in Q1 2026, with the low at $287000.0 in Q1 2022.
- Average Depreciation & Amortization (CF) over 5 years is $436882.4, with a median of $404000.0 recorded in 2023.
- Year-over-year, Depreciation & Amortization (CF) surged 137.19% in 2022 and plunged 30.44% in 2024.
- Insight Molecular Diagnostics' Depreciation & Amortization (CF) stood at $400000.0 in 2022, then decreased by 22.25% to $311000.0 in 2023, then soared by 81.67% to $565000.0 in 2024, then rose by 6.19% to $600000.0 in 2025, then grew by 5.17% to $631000.0 in 2026.
- Business Quant data shows IMDX's Depreciation & Amortization (CF) at $631000.0 in Q1 2026, $600000.0 in Q4 2025, and $584000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 36.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 306.00 Mn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 193.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 37.68 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 14.52 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 67.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 288.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 51.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 13.16 Mn |
| 10 | Insight Molecular Diagnostics | 196.41 Mn | 167.48 Mn | 15,000.00 | 631,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 631,000.00 |
| Mar 31, 2026 | 631,000.00 |
| Dec 31, 2025 | 600,000.00 |
| Dec 31, 2025 | 600,000.00 |
| Sep 30, 2025 | 584,000.00 |
| Sep 30, 2025 | 584,000.00 |
| Jun 30, 2025 | 559,000.00 |
| Jun 30, 2025 | 559,000.00 |
| Mar 31, 2025 | 491,000.00 |
| Mar 31, 2025 | 491,000.00 |
| Dec 31, 2024 | 565,000.00 |
| Dec 31, 2024 | 565,000.00 |
| Sep 30, 2024 | 318,000.00 |
| Sep 30, 2024 | 318,000.00 |
| Jun 30, 2024 | 304,000.00 |
| Jun 30, 2024 | 304,000.00 |
| Mar 31, 2024 | 313,000.00 |
| Mar 31, 2024 | 313,000.00 |
| Dec 31, 2023 | 311,000.00 |
| Dec 31, 2023 | 311,000.00 |